USE OF TISSUE FACTOR AGONIST OR TISSUE FACTOR ANTAGONIST FOR TREATMENT OF CONDITIONS RELATED TO APOPTOSIS - Patent 1443956

(19)

(11)

EP 1 443 956 A2

(12)

(88)	Date of publication A3:
	25.03.2004

(43)	Date of publication:
	11.08.2004 Bulletin 2004/33

(21)	Application number: 02772090.3

(22)	Date of filing: 01.11.2002

(51)	International Patent Classification (IPC)⁷: A61K 38/48, A61K 38/36

(86)	International application number:
	PCT/DK2002/000727

(87)	International publication number:
	WO 2003/037361 (08.05.2003 Gazette 2003/19)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

02.11.2001 DK 200101628

(71)	Applicant: Novo Nordisk Health Care AG
	8050 Zürich (CH)

(72)	Inventors:
	SORENSEN, Brit, Binow DK-3460 Birkerod (DK) PETERSEN, Lars, Christian DK-2970 Horsholm (DK)

(74)	Representative: Nilsson, Karin Norvin et al
	Novo Nordisk A/S,Corporate Patents,Novo Allé 2880 Bagsvaerd 2880 Bagsvaerd (DK)

(54)	USE OF TISSUE FACTOR AGONIST OR TISSUE FACTOR ANTAGONIST FOR TREATMENT OF CONDITIONS RELATED TO APOPTOSIS